AI assistant
IN8BIO, INC. — Director's Dealing 2024
Oct 8, 2024
35200_dirs_2024-10-08_d0dfd815-72fc-4331-9c4e-cd0eee46a3c6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IN8BIO, INC. (INAB)
CIK: 0001740279
Period of Report: 2024-10-04
Reporting Person: Brandt Peter C. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-10-04 | Common Stock | A | 253164 | — | Acquired | 517604 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-10-04 | Series A Warrants (right to buy) | $1.25 | D | 81967 | Disposed | 2025-06-13 | Common Stock (81967) | Direct |
| 2024-10-04 | Series A Warrants (right to buy) | $0.45 | A | 81967 | Acquired | 2025-10-04 | Common Stock (81967) | Direct |
| 2024-10-04 | Series C Warrants (right to buy) | $0.27 | A | 253164 | Acquired | 2027-10-04 | Common Stock (253164) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 105290 | Indirect |
Footnotes
F1: The reported securities are included within 253,164 Issuer Units purchased by the Reporting Person for $0.395 per Unit. Each Unit consists of one share of common stock and one Series C warrant representing the right to purchase 253,164 shares of common stock.
F2: The securities are held by The Peter C. Brandt 2020-4 GRAT (the "GRAT"). The Reporting Person is the trustee of the GRAT and, as such, has voting and investment power over the shares held by the GRAT.
F3: The reported transaction involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The warrant was originally granted on December 13, 2023 with an exercise price of $1.25 and expiration date of June 13, 2025. The exercise price was reduced to $0.45 and the warrant expiration date was extended to October 4, 2025.
F4: Fully vested and exercisable.
F5: The reported securities are included within 81,967 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 81,967 shares of common stock.